Zobrazeno 1 - 10
of 12
pro vyhledávání: '"H E, Bays"'
Publikováno v:
Evidence-based Cardiovascular Medicine. 7:183-185
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::19100d9329ea26e7fdf7d99dd8f20789
https://doi.org/10.1016/s1361-2611(03)00066-6
https://doi.org/10.1016/s1361-2611(03)00066-6
Autor:
Russell Cooper, James W. Anderson, Kevin C. Maki, Joseph L. Evans, M Evans, H E Bays, V Maquet
Publikováno v:
European Journal of Clinical Nutrition
BACKGROUND/OBJECTIVES: Elevated oxidized low-density lipoprotein (OxLDL) may promote inflammation, and is associated with increased risk of atherosclerotic coronary heart disease and worsening complications of diabetes mellitus. The primary objective
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::603a00df04ed93023b5def6bf670e5f8
https://pubmed.ncbi.nlm.nih.gov/22948945
https://pubmed.ncbi.nlm.nih.gov/22948945
Autor:
H W, Rodbard, H E, Bays, J R, Gavin, A J, Green, D D, Bazata, S J, Lewis, K M, Fox, M L, Reed, S, Grandy
Publikováno v:
International journal of clinical practice. 66(7)
This investigation determined the proportion of adults newly diagnosed as having type-2 diabetes mellitus (T2DM), and ascertained risk predictors for development of self-reported T2DM.The US Study to Help Improve Early evaluation and management of ri
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::8f2433b420375fecdd1e1b72db07b321
https://pubmed.ncbi.nlm.nih.gov/22698420
https://pubmed.ncbi.nlm.nih.gov/22698420
Publikováno v:
International journal of clinical practice. 64(13)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::055251a8954035bfee275c441cbe50ae
https://pubmed.ncbi.nlm.nih.gov/21070523
https://pubmed.ncbi.nlm.nih.gov/21070523
Publikováno v:
International journal of clinical practice. 64(10)
The primary objective of this study was to validate a novel Bile Acid Sequestrant Acceptability (BASA) Scale intended to assess the acceptability and/or tolerability of bile acid sequestrant (BAS) beverage preparations. A secondary objective was to a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::123475542b308add5bba1f73f4d135ad
https://pubmed.ncbi.nlm.nih.gov/20716135
https://pubmed.ncbi.nlm.nih.gov/20716135
Autor:
D, Maccubbin, H E, Bays, A G, Olsson, V, Elinoff, A, Elis, Y, Mitchel, W, Sirah, A, Betteridge, R, Reyes, Q, Yu, O, Kuznetsova, C McCrary, Sisk, R C, Pasternak, J F, Paolini
Publikováno v:
International journal of clinical practice. 62(12)
Improving lipids beyond low-density lipoprotein cholesterol (LDL-C) lowering with statin monotherapy may further reduce cardiovascular risk. Niacin has complementary lipid-modifying efficacy to statins and cardiovascular benefit, but is underutilised
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::70f8bc91020bde981a215d6c86618fd2
https://pubmed.ncbi.nlm.nih.gov/19166443
https://pubmed.ncbi.nlm.nih.gov/19166443
Autor:
H E Bays, Daniel J. Rader
Publikováno v:
International Journal of Clinical Practice
Nicotinic acid (niacin) is a well-established treatment for dyslipidaemia - an important cardiovascular disease (CVD) risk factor. However, niacin may also reduce blood pressure (BP), which is another important CVD risk factor. This review examines t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4da180455828a3a56e9a6216d1926cc5
https://pubmed.ncbi.nlm.nih.gov/19054161
https://pubmed.ncbi.nlm.nih.gov/19054161
Autor:
J F, Paolini, Y B, Mitchel, R, Reyes, S, Thompson-Bell, Q, Yu, E, Lai, D J, Watson, J M, Norquist, C McCrary, Sisk, H E, Bays
Publikováno v:
International Journal of Clinical Practice
Introduction Niacin is underutilised because of flushing. Lack of a quantitative tool to assess niacin-induced flushing has precluded the objective evaluation of flushing associated with extended-release (ER) niacin formulations. We developed the Flu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::737d6fe912bc2bcd32034dce52e4f624
https://pubmed.ncbi.nlm.nih.gov/18410350
https://pubmed.ncbi.nlm.nih.gov/18410350
Autor:
H E, Bays, C A, Dujovne
Publikováno v:
Progress in drug research. Fortschritte der Arzneimittelforschung. Progres des recherches pharmaceutiques. 43
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::92161eca4d0aff686048281a4de8a469
https://pubmed.ncbi.nlm.nih.gov/7855253
https://pubmed.ncbi.nlm.nih.gov/7855253
Publikováno v:
Heart disease and stroke : a journal for primary care physicians. 1(6)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::24b967d80cc04f97e26ae88de103f4ce
https://pubmed.ncbi.nlm.nih.gov/8179691
https://pubmed.ncbi.nlm.nih.gov/8179691